Saturday 17 October 2026
Export STE’s income statement to Excel — free account
STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
222.66
1.67
−0.74%
Follow STE
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 11.35% | 11.33% | 10.41% | 10.10% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
8 | 9 | 9 | 8 | |
| 7.62% | 7.49% | 6.87% | 6.67% | ||
ROIC |
8.27% | 7.92% | 7.24% | 7.07% | |
Return on Tangible Assets |
24.14% | 22.94% | 20.24% | 20.81% | |
Average Days of Receivables |
61.25 | 67.20 | 62.04 | 60.63 | |
Free Cash Flow per Share |
9.59 | 10.01 | 9.54 | 9.86 | |
Free Cash Flow |
936.00 | 982.90 | 936.70 | 970.40 | |
Capital Expenditures |
(352.50) | (358.50) | (330.10) | (331.00) | |
| Other line items | |||||
Cash ROIC |
9.75% | 10.27% | 9.87% | 10.50% | |
Accounts Receivable Turnover |
6.16 | 5.56 | 6.12 | 6.10 | |
Accounts Payable Turnover |
10.40 | 10.68 | 12.45 | 11.68 | |
Inventory Turnover |
4.96 | 5.46 | 4.92 | 4.72 | |
Average Days of Payables |
37.44 | 37.37 | 31.94 | 35.49 | |
Days of Inventory on Hand |
77.48 | 69.68 | 75.46 | 75.65 | |
Tax Rate |
(0.26) | (0.25) | (0.24) | (0.24) | |
Research and Development Expense of Revenue |
1.91% | 1.90% | 1.92% | 1.92% | |
Selling, General and Administrative Expense of Revenue |
23.58% | 23.72% | 23.84% | 24.08% | |
Share Based Compensation of Revenue |
1.04% | 1.04% | 1.01% | 1.02% | |
Interest Coverage |
18.84 | 18.15 | 15.94 | 14.53 | |
Operating CF/Net income |
1.60 | 1.71 | 1.79 | 1.89 | |
Depreciation/Fixed assets |
0.23 | 0.23 | 0.23 | 0.23 | |
Capex/Depreciation |
(0.72) | (0.74) | (0.68) | (0.68) | |
Revenue per Share |
61.86 | 60.45 | 59.35 | 57.95 | |
Operating CF per Share |
13.20 | 13.66 | 12.90 | 13.23 | |
Capex per Share |
(3.61) | (3.65) | (3.36) | (3.36) | |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.06 |
Columns are period end dates